Leading life science companies rely on the scientific/industrial backgrounds and strong industry relationships of our highly experienced team to provide a one-stop-shop to help commercialise, resolve patent disputes, do deals and defend product claims.
Covering the pharmaceutical, biotechnology, chemical, agricultural and healthcare sectors, life-sciences is diverse and ever-changing. Recently we have seen debate around the patentability of biological materials, as well as substantial proposed Patents Act changes major acquisitions and a consolidation within the medical device, generic and consumer health segments. Within the pharmaceutical sector, we have seen continued consultations by the TGA, statutory price reductions for PBS listed drugs and an upsurge in patent litigation as generics position themselves for early launch before expiry.
Bringing together leading corporate, finance and specialist lawyers (intellectual property, litigation, competition) our team is focused on sharing insight on the multitude of regulatory and legal developments affecting our clients. It is this deep knowledge, focus and strategic approach that differentiates King & Wood Mallesons and enables us to provide innovative commercial advice and a one-stop-shop for life science companies.